Reuters logo
BRIEF-Coherus Biosciences Q3 loss per share $1.09
November 6, 2017 / 9:16 PM / a month ago

BRIEF-Coherus Biosciences Q3 loss per share $1.09

Nov 6 (Reuters) - Coherus Biosciences Inc

* Coherus Biosciences reports third quarter 2017 operating and financial results

* Q3 loss per share $1.09

* Q3 earnings per share view $-0.81 -- Thomson Reuters I/B/E/S

* Coherus biosciences inc - ‍anticipate cash use in operations of about $35 - $40 million in Q4 of 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below